← Back to Search

Behavioral Intervention

Coach McLungs Intervention for Asthma

N/A
Recruiting
Led By Hazel Tapp, PhD
Research Sponsored by Atrium Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Established mild, moderate, or severe persistent asthma
English or Spanish speaking.
Must not have
Decisional impaired or mentally incompetent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will test how well an online asthma education and decision-making tool works when incorporated into primary care.

Who is the study for?
This trial is for children and teens aged 5-17 with mild to severe persistent asthma who can communicate in English or Spanish. It's not suitable for those who have decision-making impairments or are mentally incompetent.
What is being tested?
The study tests the Coach McLungsSM intervention, a virtual tool designed to help manage asthma through education and clinical support. The effectiveness will be measured by looking at emergency visits, hospital stays, and oral steroid use due to asthma.
What are the potential side effects?
Since Coach McLungsSM is an educational and supportive intervention rather than a medication, it does not have traditional side effects. However, there may be indirect effects on patient behavior or healthcare utilization.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with persistent asthma.
Select...
I speak English or Spanish.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am able to make my own health decisions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Asthma

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: ControlActive Control1 Intervention
Coach McLungs not yet implemented in practice
Group II: InterventionActive Control1 Intervention
Coach McLungs Implemented in Practice

Find a Location

Who is running the clinical trial?

Atrium HealthLead Sponsor
121 Previous Clinical Trials
32,233 Total Patients Enrolled
2 Trials studying Asthma
1,070 Patients Enrolled for Asthma
Wake Forest University Health SciencesLead Sponsor
1,403 Previous Clinical Trials
2,475,235 Total Patients Enrolled
7 Trials studying Asthma
41,942 Patients Enrolled for Asthma
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,943 Previous Clinical Trials
47,795,193 Total Patients Enrolled
282 Trials studying Asthma
111,723 Patients Enrolled for Asthma
Hazel Tapp, PhDPrincipal InvestigatorWake Forest University Health Sciences

Media Library

Coach McLungs Intervention (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05059210 — N/A
Asthma Research Study Groups: Control, Intervention
Asthma Clinical Trial 2023: Coach McLungs Intervention Highlights & Side Effects. Trial Name: NCT05059210 — N/A
Coach McLungs Intervention (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05059210 — N/A
~502 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top